Noha Abdel‐Wahab

4.5k total citations · 1 hit paper
60 papers, 2.3k citations indexed

About

Noha Abdel‐Wahab is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Noha Abdel‐Wahab has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 10 papers in Immunology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Noha Abdel‐Wahab's work include Cancer Immunotherapy and Biomarkers (38 papers), CAR-T cell therapy research (13 papers) and Colorectal Cancer Treatments and Studies (10 papers). Noha Abdel‐Wahab is often cited by papers focused on Cancer Immunotherapy and Biomarkers (38 papers), CAR-T cell therapy research (13 papers) and Colorectal Cancer Treatments and Studies (10 papers). Noha Abdel‐Wahab collaborates with scholars based in United States, Egypt and Vietnam. Noha Abdel‐Wahab's co-authors include María E. Suarez‐Almazor, Mohsin Shah, María A. López-Olivo, Adi Diab, Ala Abudayyeh, Jean Tayar, Heather Lin, Cassian Yee, Houssein Safa and Daniel H. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Noha Abdel‐Wahab

59 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease

2018 340 citations Noha Abdel‐Wahab, María A. López-Olivo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noha Abdel‐Wahab United States	22	1.6k	441	414	304	286	60	2.3k
Selim Corbacioglu Germany	29	643 0.4×	286 0.6×	459 1.1×	185 0.6×	428 1.5×	105	2.7k
Kim Vettenranta Finland	31	654 0.4×	248 0.6×	290 0.7×	366 1.2×	249 0.9×	167	3.4k
Nicole A. Aqui United States	18	867 0.5×	274 0.6×	1.3k 3.1×	293 1.0×	569 2.0×	41	3.4k
Taner Demirer Türkiye	31	1.2k 0.7×	247 0.6×	763 1.8×	232 0.8×	512 1.8×	101	3.2k
Cassandra Calabrese United States	20	633 0.4×	183 0.4×	333 0.8×	165 0.5×	183 0.6×	63	1.5k
Adrian Goycoolea	2	796 0.5×	247 0.6×	556 1.3×	355 1.2×	424 1.5×	3	2.8k
Yukihiro Imai Japan	28	1.2k 0.7×	1.3k 3.1×	178 0.4×	312 1.0×	150 0.5×	203	2.8k
Patrick Lutz France	26	490 0.3×	269 0.6×	326 0.8×	477 1.6×	472 1.7×	62	2.3k
Claire Cropet France	23	1.8k 1.1×	1.4k 3.2×	203 0.5×	298 1.0×	290 1.0×	95	3.2k
Masahiro Tsuchida Japan	34	963 0.6×	255 0.6×	944 2.3×	210 0.7×	527 1.8×	160	4.3k

Countries citing papers authored by Noha Abdel‐Wahab

Since Specialization

Citations

This map shows the geographic impact of Noha Abdel‐Wahab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noha Abdel‐Wahab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noha Abdel‐Wahab more than expected).

Fields of papers citing papers by Noha Abdel‐Wahab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noha Abdel‐Wahab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noha Abdel‐Wahab. The network helps show where Noha Abdel‐Wahab may publish in the future.

Co-authorship network of co-authors of Noha Abdel‐Wahab

This figure shows the co-authorship network connecting the top 25 collaborators of Noha Abdel‐Wahab. A scholar is included among the top collaborators of Noha Abdel‐Wahab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noha Abdel‐Wahab. Noha Abdel‐Wahab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdel‐Wahab, Noha, Sreyashi Basu, Yuwei Zhang, et al.. (2025). Interrogating the interleukin-6 (IL-6)/IL-23/T-helper (Th)17 axis in immunotherapy toxicity: Mechanistic insights and therapeutic implications.. Journal of Clinical Oncology. 43(16_suppl). 12134–12134. 1 indexed citations

Ye, Carrie, et al.. (2024). Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitors. SHILAP Revista de lepidopterología. 3(1). e000398–e000398. 4 indexed citations

Johnson, Daniel H., Rodabe N. Amaria, Isabella Claudia Glitza, et al.. (2024). Phase II trial of weekly or bi-weekly tocilizumab with ipilimumab and nivolumab in advanced melanoma: Clinical outcomes and biomarker analysis.. Journal of Clinical Oncology. 42(16_suppl). 9553–9553. 8 indexed citations

Abdel‐Wahab, Noha, et al.. (2023). The Preoperative Administration of Nebulized Dexmedetomidine Versus Nebulized Midazolam as a Sedative Premedication before Pediatric Surgery. 30(5). 2 indexed citations

Abdel‐Wahab, Noha, et al.. (2023). Fabrication and characterization of novel biocomposite based on Sargassum vulgare for controlling sugar beet root diseases. Chemical and Biological Technologies in Agriculture. 10(1). 6 indexed citations

Bass, Anne R., Noha Abdel‐Wahab, Pankti Reid, et al.. (2023). Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Annals of the Rheumatic Diseases. 82(7). 920–926. 39 indexed citations

Abdel‐Wahab, Noha, et al.. (2023). The Preoperative Administration Of Nebulized Dexmedetomidine Versus Nebulized Midazolam as a Sedative Premedication before Pediatric Surgery. 30(4). 2 indexed citations

Selamet, Umut, Omar Mamlouk, Juhee Song, et al.. (2023). Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response. Cancers. 15(21). 5181–5181. 8 indexed citations

Bass, Anne R., Noha Abdel‐Wahab, Pankti Reid, et al.. (2023). OP0029 COMPARATIVE SAFETY AND EFFECTIVENESS OF TNF INHIBITORS, IL6R INHIBITORS AND METHOTREXATE FOR THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED ARTHRITIS. Annals of the Rheumatic Diseases. 82. 19–19. 1 indexed citations

10.

Awiwi, Muhammad O., Ala Abudayyeh, Noha Abdel‐Wahab, et al.. (2022). Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: a retrospective series of biopsy-proven cases. European Radiology. 33(3). 2227–2238. 13 indexed citations

11.

Awiwi, Muhammad O., Ala Abudayyeh, Noha Abdel‐Wahab, et al.. (2022). Radiologic features of immune checkpoint inhibitor-related nephritis with clinical correlation in biopsy-proven cases.. Journal of Clinical Oncology. 40(16_suppl). e14585–e14585. 1 indexed citations

12.

López-Olivo, María A., et al.. (2021). Quality appraisal of educational websites about osteoporosis and bone health. Archives of Osteoporosis. 16(1). 28–28. 1 indexed citations

13.

Diab, Adi, Noha Abdel‐Wahab, Daniel H. Johnson, et al.. (2021). 72P Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Annals of Oncology. 32. S1403–S1403. 1 indexed citations

14.

Diab, Adi, Noha Abdel‐Wahab, Salah-Eddine Bentebibel, et al.. (2021). 169TiP Tocilizumab, ipilimumab, and nivolumab for the treatment of advanced melanoma, non-small cell lung cancer, or urothelial carcinoma. Annals of Oncology. 32. S1456–S1456. 1 indexed citations

15.

Abdel‐Wahab, Noha, Adi Diab, Robert Yu, et al.. (2021). Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors. Cancer Immunology Immunotherapy. 70(7). 1939–1949. 46 indexed citations

16.

Pundole, Xerxes, Sudhakar Tummala, Clark R. Andersen, et al.. (2020). THU0336 IMMUNE CHECKPOINT INHIBITOR-RELATED MYOSITIS: A RETROSPECTIVE COHORT STUDY. Annals of the Rheumatic Diseases. 79. 399–399. 2 indexed citations

17.

Abdel‐Wahab, Noha, Robert Yu, Adi Diab, et al.. (2019). Genetic determinants of adverse events in cancer patients receiving immune checkpoint inhibitors.. Journal of Clinical Oncology. 37(15_suppl). 2586–2586. 1 indexed citations

18.

Mamlouk, Omar, Umut Selamet, Maen Abdelrahim, et al.. (2019). Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. Journal for ImmunoTherapy of Cancer. 7(1). 2–2. 199 indexed citations

19.

Bordes, Jude des, Noha Abdel‐Wahab, María E. Suarez‐Almazor, & María A. López-Olivo. (2015). Assessing information needs on bone health in cancer survivors. Journal of Cancer Survivorship. 10(3). 480–488. 9 indexed citations

20.

Mosad, Eman, et al.. (2011). Early predictors of increased bone resorption in juvenile idiopathic arthritis: OPG/RANKL ratio, as a key regulator of bone metabolism. The Egyptian Rheumatologist. 33(4). 217–223. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact